Loading organizations...
Key people at iBionext.
iBionext was founded in 2012 by Bernard Gilly (Founder & Chairman) and Alexia Perouse (Co-Founder & CEO).
iBionext is a venture studio based in Paris, France, that finances and supports early-stage companies developing disruptive innovations in healthcare and deep tech. The organization builds, accompanies, and leads the financing of innovative startups, covering the full innovation-to-growth financing chain via its iBionext Growth Fund. Operating an ecosystem model, its portfolio companies are co-located in the "Passage de l'Innovation" in Paris, focusing on biotech, medtech, and connected medical devices. Since 2012, iBionext has participated in creating at least seven companies, including Pixium Vision, GenSight Biologics (listed on Euronext), Gecko Biomedical, and ChronoLife. The studio notably made an initial investment in Chronocam's $15M Series B financing. Led by Chairman Bernard Gilly and CEO & Managing Partner Alexia Perouse, iBionext was founded in 2015 by Bernard Gilly.
iBionext was founded in 2012 by Bernard Gilly (Founder & Chairman) and Alexia Perouse (Co-Founder & CEO).
iBionext has 1 tracked investment across 1 company. The latest tracked deal is $48.0M Series C in Prophesee in September 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2022 | Prophesee | $48.0M Series C | — | Prosperity7 Ventures, 360 Capital Partners, European Investment Bank, Intel Capital, Robert Bosch Venture Capital, Sinovation Ventures, Xiaomi |
Key people at iBionext.